Published in Bioorg Med Chem Lett on January 03, 2008
Developing β-secretase inhibitors for treatment of Alzheimer's disease. J Neurochem (2011) 1.37
Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J (2010) 1.29
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. Chem Soc Rev (2014) 1.14
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease. J Med Chem (2009) 1.05
Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity. Biochemistry (2014) 1.00
Inhibition of BACE1 for therapeutic use in Alzheimer's disease. Int J Clin Exp Pathol (2010) 0.92
Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity. Neural Plast (2012) 0.86
Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine. J Org Chem (2010) 0.85
Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure. J Med Chem (2012) 0.84
Neuronal death in Alzheimer's disease and therapeutic opportunities. J Cell Mol Med (2009) 0.84
Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression. Curr Alzheimer Res (2015) 0.79
Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol Psychiatry (2016) 0.79
Developing BACE-1 inhibitors for FXS. Front Cell Neurosci (2013) 0.78
Expression and processing of fluorescent fusion proteins of amyloid precursor protein (APP). Biochim Biophys Acta (2013) 0.77
Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications. Age (Dordr) (2010) 0.77
Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands. Bioorg Med Chem Lett (2015) 0.76
Design of Potent and Highly Selective Inhibitors for Human β-Secretase 2 (Memapsin 1), a Target for Type 2 Diabetes. Chem Sci (2016) 0.75
Discovery of potent beta-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids. Acta Pharmacol Sin (2009) 0.75
Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors. Bioorg Med Chem Lett (2012) 0.75
Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex. Bioorg Med Chem (2017) 0.75
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci (2001) 6.32
Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (1999) 5.42
Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A (2000) 2.96
Cathepsin D is membrane-associated in macrophage endosomes. J Biol Chem (1988) 2.35
Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science (2000) 2.01
Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A (1999) 1.98
Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). J Med Chem (2004) 1.87
Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design. Biochemistry (2001) 1.29
In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors. J Neurochem (2004) 1.23
Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates. Biochemistry (2000) 1.18
Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity. Biochemistry (2002) 1.11
Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase). J Med Chem (2001) 1.10
Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands. J Med Chem (2007) 1.09
Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3. Biochemistry (2002) 1.04
Design, synthesis and X-ray structure of protein-ligand complexes: important insight into selectivity of memapsin 2 (beta-secretase) inhibitors. J Am Chem Soc (2006) 0.97
Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization. FASEB J (2007) 0.93
Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (beta-secretase). Bioorg Med Chem Lett (2005) 0.93
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase. J Med Chem (2007) 0.92
Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease. Curr Top Med Chem (2005) 0.88
The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol (2000) 0.83
White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. Neuroimage (2012) 5.02
Image distortion correction in fMRI: A quantitative evaluation. Neuroimage (2002) 4.64
Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45
A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell (2006) 3.38
A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat Cell Biol (2003) 3.11
Critical comments on dynamic causal modelling. Neuroimage (2011) 2.49
Learning partially directed functional networks from meta-analysis imaging data. Neuroimage (2009) 2.43
Cortico-striatal connections predict control over speed and accuracy in perceptual decision making. Proc Natl Acad Sci U S A (2010) 2.28
Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy (2008) 2.21
Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractography. Neuroimage (2002) 2.14
Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sites. BMC Biotechnol (2006) 2.01
GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem (2004) 1.99
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat Genet (2005) 1.97
Voxel-based cortical thickness measurements in MRI. Neuroimage (2008) 1.82
Universal recognition of three basic emotions in music. Curr Biol (2009) 1.81
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study. Leuk Lymphoma (2010) 1.79
beta-Secretase as a therapeutic target for Alzheimer's disease. Neurotherapeutics (2008) 1.74
Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage (2012) 1.60
An embedded optical tracking system for motion-corrected magnetic resonance imaging at 7T. MAGMA (2012) 1.54
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172). Leuk Lymphoma (2011) 1.52
Fast MRI coil analysis based on 3-D electromagnetic and RF circuit co-simulation. J Magn Reson (2009) 1.52
Diffusion imaging in humans at 7T using readout-segmented EPI and GRAPPA. Magn Reson Med (2010) 1.51
Eigenvector centrality mapping for analyzing connectivity patterns in fMRI data of the human brain. PLoS One (2010) 1.48
Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion. Mol Pharm (2014) 1.45
Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance. ChemMedChem (2006) 1.40
Enantioselective total synthesis of (+)-largazole, a potent inhibitor of histone deacetylase. Org Lett (2008) 1.40
Optimized EPI for fMRI studies of the orbitofrontal cortex: compensation of susceptibility-induced gradients in the readout direction. MAGMA (2007) 1.39
Microstructural Parcellation of the Human Cerebral Cortex - From Brodmann's Post-Mortem Map to in vivo Mapping with High-Field Magnetic Resonance Imaging. Front Hum Neurosci (2011) 1.38
Bilateral decompression of lumbar spinal stenosis involving a unilateral approach with microscope and tubular retractor system. J Neurosurg (2002) 1.37
Developing β-secretase inhibitors for treatment of Alzheimer's disease. J Neurochem (2011) 1.37
Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol (2006) 1.36
Song and speech: brain regions involved with perception and covert production. Neuroimage (2006) 1.35
Enantioselective total synthesis of peloruside A: a potent microtubule stabilizer. Org Lett (2008) 1.31
Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2003) 1.30
High-resolution fast spin echo imaging of the human brain at 4.7 T: implementation and sequence characteristics. Magn Reson Med (2004) 1.30
Memapsin 2 (beta-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2: implications on the endocytosis mechanism of memapsin 2. FEBS Lett (2002) 1.30
Tracking the unconscious generation of free decisions using ultra-high field fMRI. PLoS One (2011) 1.29
Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J (2010) 1.29
The Rho GTP exchange factor Lfc promotes spindle assembly in early mitosis. Proc Natl Acad Sci U S A (2005) 1.28
Apolipoprotein receptor 2 and X11 alpha/beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production. J Neurosci (2007) 1.27
Ultra-high 7T MRI of structural age-related changes of the subthalamic nucleus. J Neurosci (2013) 1.26
Cortico-subthalamic white matter tract strength predicts interindividual efficacy in stopping a motor response. Neuroimage (2011) 1.24
Biochemical and structural characterization of the interaction of memapsin 2 (beta-secretase) cytosolic domain with the VHS domain of GGA proteins. Biochemistry (2003) 1.23
In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors. J Neurochem (2004) 1.23
Statistical inference and multiple testing correction in classification-based multi-voxel pattern analysis (MVPA): random permutations and cluster size control. Neuroimage (2012) 1.22
k-space and q-space: combining ultra-high spatial and angular resolution in diffusion imaging using ZOOPPA at 7 T. Neuroimage (2012) 1.22
MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett (2009) 1.22
Breast implant infection with Mycobacterium fortuitum group: report of case and review. J Infect (2005) 1.20
How the brain tissue shapes the electric field induced by transcranial magnetic stimulation. Neuroimage (2011) 1.18
The biosynthesis of spinosyn in Saccharopolyspora spinosa: synthesis of the cross-bridging precursor and identification of the function of SpnJ. J Am Chem Soc (2007) 1.17
Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum Brain Mapp (2011) 1.16
Diffusion tensor imaging segments the human amygdala in vivo. Neuroimage (2009) 1.14
Rhythm in disguise: why singing may not hold the key to recovery from aphasia. Brain (2011) 1.14
Cerebral vascular response to hypercapnia: determination with perfusion MRI at 1.5 and 3.0 Tesla using a pulsed arterial spin labeling technique. J Magn Reson Imaging (2006) 1.13
Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity. Biochemistry (2002) 1.11
Characterization of protein encoded by spnR from the spinosyn gene cluster of Saccharopolyspora spinosa: mechanistic implications for forosamine biosynthesis. J Am Chem Soc (2005) 1.11
Memapsin 2 (beta-secretase) inhibitors: drug development. Curr Alzheimer Res (2008) 1.10
Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands. J Med Chem (2007) 1.09
Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol (2005) 1.09
FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. Mol Cell Biol (2004) 1.09
Setting the frame: the human brain activates a basic low-frequency network for language processing. Cereb Cortex (2009) 1.08
Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV. Angew Chem Int Ed Engl (2012) 1.08
Characterization of TDP-4-keto-6-deoxy-D-glucose-3,4-ketoisomerase from the D-mycaminose biosynthetic pathway of Streptomyces fradiae: in vitro activity and substrate specificity studies. Biochemistry (2007) 1.07
A 16-channel dual-row transmit array in combination with a 31-element receive array for human brain imaging at 9.4 T. Magn Reson Med (2014) 1.07
The interaction of covalently bound heme with the cytochrome c maturation protein CcmE. J Biol Chem (2004) 1.06
Do the congenitally blind have a stria of Gennari? First intracortical insights in vivo. Cereb Cortex (2011) 1.06
Layer-specific intracortical connectivity revealed with diffusion MRI. Cereb Cortex (2012) 1.04
Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3. Biochemistry (2002) 1.04
Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J Leukoc Biol (2004) 1.04
Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (beta-secretase). Biochemistry (2005) 1.03
Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev (2010) 1.03
Neuroanthropology: a humanistic science for the study of the culture-brain nexus. Soc Cogn Affect Neurosci (2009) 1.02
Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. Bioorg Med Chem Lett (2007) 1.02
Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis. Biochemistry (2004) 1.01
Echo time dependence of BOLD contrast and susceptibility artifacts. Neuroimage (2002) 1.00
Bilateral decompressive surgery in lumbar spinal stenosis associated with spondylolisthesis: unilateral approach and use of a microscope and tubular retractor system. Neurosurg Focus (2002) 0.99
The Escherichia coli cytochrome c maturation (Ccm) system does not detectably attach heme to single cysteine variants of an apocytochrome c. J Biol Chem (2002) 0.99
Expression quantitative trait loci analysis of two genes encoding rubisco activase in soybean. Plant Physiol (2009) 0.99
Brain changes after learning to read and play music. Neuroimage (2003) 0.98
Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis (2013) 0.98
An anterior-posterior gradient of cognitive control within the dorsomedial striatum. Neuroimage (2012) 0.98